Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic

7th February 2024 Uncategorised 0

Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic
fkansteiner
Wed, 02/07/2024 – 11:04

More: Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic
Source: fierce